ليست عنوان مقالات لاتين Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats Orangutan population density, forest structure and fruit availability in hand-logged and unlogged peat swamp forests in West Kalimantan, Indonesia Original Research Article

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats

2

Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL/6N mice

3

Oral administration of heparin or heparosan increases the Lactobacillus population in gut microbiota of rats

4

Oral Administration of IL-12 Suppresses Anaphylactic Reactions in a Murine Model of Peanut Hypersensitivity

5

Oral administration of IL-1β enhanced the proliferation of lymphocytes and the O2− production of neutrophil in newborn calf

6

Oral administration of IL-1β enhanced the proliferation of lymphocytes and the O2− production of neutrophil in newborn calf

7

Oral administration of insulin included in fine W/O/W emulsions to rats

8

Oral administration of leaf extracts to rumen liquid donor lambs modifies in vitro gas production of other tree leaves

9

Oral administration of marijuana produces alterations in serotonin 5-hydroxytryptamine receptor 3A gene (HTR3A) and electrolyte imbalances in brain of male Wistar rats

10

Oral Administration of Morphine Delays Neural Plate Development in Rat Embryos

11

Oral administration of Nitraria retusa ethanolic extract enhances hepatic lipid metabolism in db/db mice model ‘BKS.Cg-Dock7m+/+ Leprdb/J’ through the modulation of lipogenesis–lipolysis balance

12

Oral administration of NO synthase inhibitor failed to promote arteriosclerotic lesions in the aorta and the coronary arteries of rabbits fed cholesterol Original Research Article

13

ORAL ADMINISTRATION OF NUTMEG ON MEMORY BOOSTING AND REGAINING IN WISTAR ALBINO RATS

14

Oral administration of omega-7 palmitoleic acid induces satiety and the release of appetite-related hormones in male rats

15

ORAL ADMINISTRATION OF PEPTIDERGIC GROWTH HORMONE (GH) SECRETAGOGUE KP102 STIMULATES GH RELEASE IN GOATS

16

oral administration of probiotic enterococcus durans to ameliorate experimental autoimmune encephalomyelitis in mice

17

Oral administration of rac-α-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial

18

Oral administration of recombinant epinecidin-1 protected grouper (Epinephelus coioides) and zebrafish (Danio rerio) from Vibrio vulnificus infection and enhanced immune-related gene expressions

19

Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis

20

Oral administration of tepoxalin in the horse: A PK/PD study

21

Oral Administration of Testosterone in Fish Diet Affect Sex Differentiation and Testis Development in Tilapia.

22

Oral Administration of the Aqueous Extract of Rosmarinus Officinalis in Rats Before Renal Reperfusion Injury

23

Oral administration of the nitric oxide biosynthesis inhibitor, N-nitro-l-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats

24

Oral administration of titanium dioxide nanoparticle through ovarian tissue alterations impairs mice embryonic development

25

Oral administration of titanium dioxide nanoparticle through ovarian tissue alterations impairs mice embryonic development

26

Oral administration of triethylenetetramine (TETA) reduces some inflammatory markers in streptozotocin-induced diabetes mellitus in rat

27

Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults

28

Oral administration of type II collagen suppresses non-specifically induced chronic arthritis in rats

29

Oral administration of type-II collagen peptide 250–270 suppresses specific cellular and humoral immune response in collagen-induced arthritis

30

Oral Administration of Vitamin C, Cimetidine and Famotidine on Micronuclei Induced by Low Dose Radiation in Mouse Bone Marrow Cells

31

Oral administration of yeast, Saccharomyces cerevisiae, enhances the cellular innate immune response of gilthead seabream (Sparus aurata L.)

32

Oral administration of yeast, Saccharomyces cerevisiae, enhances the cellular innate immune response of gilthead seabream (Sparus aurata L.)

33

Oral Administration of Zataria multiflora Extract Decreases IL-17 Expression in Perennial Allergic Rhinitis

34

Oral administration of zinc sulphate in treatment of acute cutaneous leishmaniasis

35

Oral administration versus intra-peritoneal injection of Pb affects its concentration in selected rat tissues

36

Oral agents for the treatment of type 2 diabetes mellitus: Pharmacology, toxicity, and treatment

37

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

38

Oral Allergy Syndrome Associated with Jicama

39

Oral allopurinol desensitization

40

Oral ambroxol supplement in pregnant women induces fetal lung maturation

41

Oral Ambu-bag insufflation to remove unilateral nasal foreign bodies

42

Oral Amelanotic Melanoma of the Maxilla

43

Oral Amino Acid Administration Decreases Oxidative Stress and Improves Brachial Reactivity in Elderly Individuals

44

Oral amino acid administration in patients with diabetes mellitus: supplementation or metabolic therapy?

45

Oral amiodarone and atrial fibrillation

46

Oral amiodarone and atrial fibrillation

47

Oral amiodarone and atrial fibrillation

48

Oral amiodarone and atrial fibrillation

49

Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial

50

Oral amiodarone reduces incidence of postoperative atrial fibrillation

51

Oral amoxicillin for childhood pneumonia

52

Oral amoxicillin for childhood pneumonia

53

Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study

54

Oral Amoxicillin-Clavulanic Acid Treatment in Urinary Tract Infections Caused by Extended-Spectrum Beta-Lactamase–Producing Organisms

55

Oral analgesia compared with intravenous patient-controlled analgesia for pain after cesarean delivery: A randomized controlled trial

56

Oral and anal immunisation with alloantigen induces active cell-mediated cytotoxic responses in carp

57

Oral and Colonic Microbiomes and Colon Cancer

58

Oral and dental complications caused by methamphetamine use: A Review

59

Oral and dental health in hospitalized psychiatric patients: a cross-sectional and comparative study in Kerman, Iran

60

Oral and dental health of non-institutionalized elderly people in Spain

61

Oral and Dental Health Status in Patients with Primary Antibody Deficiencies

62

Oral and Dental Laser Treatments for Children: Applications, Advantages and Considerations

63

Oral and Dental Status, Oral Health-Related Quality of Life and Associated Factors among Institutionalized Elderly in Southeast Iran-A Cross Sectional Study

64

Oral and injectable synthetic progestagens effectively manipulate the estrous cycle in the Przewalskiʹs horse (Equus ferus przewalskii)

65

Oral and intestinal digestion of oligosaccharides as potential sweeteners: A systematic evaluation

66

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections

67

Oral and Intravenous ltraconazole for Systemic Fungal Infections in Neutropenic Haematological Patients: Meeting Report

68

Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: Pharmacokinetic considerations and clinical implications

69

Oral and Jaw Lesions in Adults: A 19-Year Retrospective Study In Northern Iran

70

Oral and Laryngeal Diadochokinetic Rate in Multiple Sclerosis: Relationship to Disease Progression

71

Oral and maxillofacial complications of COVID-19 infection: A review

72

Oral and Maxillofacial Injuries in Civilian Recruits During Mandatory Combat Training at Military Garrisons: A Nationwide Survey

73

Oral and Maxillofacial Lesions in an Elderly Population in Shiraz, Iran

74

Oral and maxillofacial manifestations of hereditary sensory neuropathy

75

Oral and Maxillofacial Manifestations of Neurological Diseases in Southern Provinces of Iran

76

Oral and maxillofacial medicine curriculum and practice for undergraduate dental students: A comparative study of Iranian universities and other countries

77

Oral and Maxillofacial Pathology in Three Dimensions

78

Oral and maxillofacial tumours in children and adolescents: Clinicopathologic audit of 75 cases in an academic medical centre, Sokoto, Northwest Nigeria

79

Oral and maxillofacial tumours in children: a review

80

Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses

81

Oral and parenteral vaccination of mice with protein-ergotamine conjugates and evaluation of protection against fescue toxicosis

82

Oral and parenteral vaccination of mice with protein-ergotamine conjugates and evaluation of protection against fescue toxicosis

83

Oral and Pharyngeal Cancer in Women

84

Oral and pharyngeal cancers in Yemen: a retrospective study

85

Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Aβ(25–35)-induced abnormal tau protein immunoreactivity in rat brain

86

Oral and Systemic Conditions in Elderly Population Groups in Talash, North of Iran

87

Oral and Systemic Conditions in Elderly Population Groups in Talash, North of Iran

88

Oral and Systemic Conditions in Elderly Population Groups in Talash, North of Iran

89

Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals

90

Oral and vulvar changes in pregnancy

91

Oral antibiotic administration and early hospital discharge is a safe and effective alternative for treatment of low-risk neutropenic fever: Abstracted from: Innes HE, Smith DB, O’Reilly SM et al. Oral antibiotics with early hospital discharge compared wi

92

Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy

93

Oral Antibiotic Use Following Stented Hypospadias Repair: Does It Play a Role in the Prevention of Urinary Tract Infections?

94

Oral Antibiotic use without consulting a Physician: A survey of ED patients

95

Oral antibiotics better in low-risk cancer patients

96

Oral antibiotics for the treatment of severe pneumonia in children

97

Oral anticoagulant therapy—An algorithm to facilitate control

98

Oral anticoagulants and fetal loss

99

Oral anticoagulants and fetal loss

100

Oral anticoagulants and fetal loss

101

Oral anticoagulants and fetal loss

102

Oral anticoagulants and fracture risk: Clinical perspectives

103

Oral anticoagulants in patients with coronary artery disease

104

Oral anticoagulants: Pharmacogenetics: Relationship between genetic and non-genetic factors

105

Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention

106

Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort

107

Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison

108

Oral anticoagulation strategies after a first idiopathic venous thromboembolic event

109

Oral Antidiabetic Utilization and Various Factors as an Indicator for HbA1c Control Among Patients with Type 2 Diabetes

110

Oral antifungal agents for onychomycosis

111

Oral antifungal agents for onychomycosis

112

Oral antifungals as prophylaxis in haematological malignancy

113

Oral antihypertensive trial design and analysis under the pediatric exclusivity provision

114

Oral Aphthous: Pathophysiology, Clinical Aspects and Medical Treatment

115

Oral arginine supplementation in acute liver injury

116

Oral arsenic trioxide poisoning and secondary hazard from gastric content

117

Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial Original Research Article

118

Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat

119

Oral Bacteria and Colorectal Pathology

120

Oral bacterial deactivation using a low-temperature atmospheric argon plasma brush

121

Oral bacterial deactivation using a low-temperature atmospheric argon plasma brush

122

Oral Bacterial Ecology. The Molecular Basis: H.K. Kuramitsu and R.P. Ellen. Horizon Scientific Press, England, 2000; 314 pages, hard back; £74.79; US $149.99; ISBN: 1-898486-22-0; http://www.horizonpress.com: E-mail: griffin@horizonpress.com

123

Oral bacterial lipopolysaccharide acts in mice to promote sensitisation to ovalbumin and to augment anaphylaxis via platelets

124

Oral behaviour of food hydrocolloids and emulsions. Part 1. Lubrication and deposition considerations

125

Oral behaviour of food hydrocolloids and emulsions. Part 2. Taste and aroma release

126

Oral bioaccessibility and human risk assessment of organochlorine pesticides (OCPs) via fish consumption, using an in vitro gastrointestinal model

127

Oral bioaccessibility of potentially toxic elements (PTEs) in urban dusts of Abakaliki,Ebonyi State, Nigeria

128

Oral bioaccessibility testing and read-across hazard assessment of nickel compounds

129

Oral bioavailability and pharmacokinetic study of cetrizine HCl in Iranian healthy volunteers

130

Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS

131

Oral Bioavailability of Quercetin in Horses

132

Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles

133

Oral bioavailability, tissue distribution and depletion of flumequine in the food producing animal, chicken for fattening

134

Oral biodrug delivery using cell-penetrating peptide

135

Oral Biopsy: A Dental Gawk

136

Oral blistering diseases

137

Oral blockade of the platelet glycoprotein IIb/IIIa receptor: Fact or fancy?,

138

Oral bone loss induced by mineral deficiency in a rat model: Effect of a synthetic bone mineral (SBM) preparation

139

Oral Breathing Increases Pth and Vocal Effort by Superficial Drying of Vocal Fold Mucosa

140

Oral cadmium exposure throughout puberty does not inhibit secretion of prolactin, GH and ACTH through dopamine metabolism changes in male rat

141

Oral Cancer Awareness among Dentists in Kuwait

142

Oral Cancer Awareness and Knowledge among Marginalised Group in Sungai Petani, Kedah, Malaysia

143

Oral Cancer Detection

144

Oral cancer early symptom variations: pain as the first symptom in oral cancer patients

145

Oral cancer exams among cigarette smokers in Maryland

146

Oral Cancer in Developing Countries: The Time to Act Is Upon Us

147

Oral Cancer Knowledge among Patients Referred to Mashhad Dental School, Iran

148

Oral Cancer Prevention: The Case for Carotenoids and Anti-Oxidant Nutrients

149

Oral cancer screening: 5 minutes to save a life

150

Oral cancer, fever of unknown origin, and listeriosis

151

Oral cancer, smoking and alcohol: the patients’ perspective

152

Oral cancer: a retrospective study of 100 Danish cases

153

Oral cancer: leukoplakia and squamous cell carcinoma

154

Oral Cancer: Leukoplakia, Premalignancy, and Squamous Cell Carcinoma

155

Oral cancer: Nanoparticles as a new horizon in the diagnosis and phototherapy-based therapies

156

Oral Cancer: Prevention and Early Detection, Dentists’ Opinions and Practices (Mashhad-Iran)

157

Oral cancer—pertinent papers 2002–2003 A personal view

158

Oral Cancer—pertinent papers 2003–2004: A personal view

159

Oral Candida albicans biotypes in chinese patients with and without oral candidosis

160

Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy

161

Oral Candidal Infections and Treatment

162

Oral Candidiasis among Cancer Patients Attending a Tertiary Care Hospital in Chennai, South India: An Evaluation of Clinicomycological Association and Antifungal Susceptibility Pattern

163

Oral candidiasis and nutritional deficiencies in elderly hospitalised patients

164

Oral Candidiasis in Hematological Malignancy Patients: Identification and Antifungal Susceptibility Patterns of Isolates

165

Oral candidosis:

166

Oral cannabinoids for spasticity in multiple sclerosis: will attitude continue to limit use?

167

Oral Capecitabine Achieves Response in MetastaticEccrine Carcinoma

168

Oral Capecitabine in Combination with Gemcitabine in Management of Advanced Pancreatic Carcinoma

169

Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)

170

Oral carcinogenesis induced by 4-nitroquinoline 1-oxide in lecithin:retinol acyltransferase gene knockout mice

171

Oral care and pneumonia

172

Oral Care as A Subject of Patient Safety in Neurosurgical Intensive Care Units

173

Oral Care during Mechanical Ventilation Significantly Reduces the Incidence of Ventilator-Associated Pneumonia

174

Oral care experiences with 181 nasopharyngeal carcinoma patients receiving radiotherapy in a Taiwanese hospital

175

Oral care help to maintain nutritional status in frail older people

176

Oral Care in Patients Receiving Mechanical Ventilator

177

Oral Care in Trauma Patients Admitted to the ICU: Viewpoints of ICU Nurses

178

Oral Care Program for Successful Long-Term Full Mouth Habilitation of Patients with Hypohidrotic Ectodermal Dysplasia

179

Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients

180

ORAL CAVITY CANCERS AND CLASSIFICATION

181

ORAL CAVITY CANCERS IN NORTH WEST PAKISTAN: A HOSPITAL BASED STUDY

182

Oral cavity cancers treated with superselective intra-arterial chemoradiotherapy with radiation doses less than 60 Gy: implications for dose reduction from a propensity score-matched analysis

183

Oral Cavity Lesions in Patients after Chemotherapy

184

Oral Cephalosporin Cefodox for treatment of out patient pneumonia in children

185

Oral chlodronate in pagetʹs disease

186

Oral Chloral Hydrate Compare with Rectal Thiopental in Pediatric Procedural Sedation and Analgesia; a Randomized Clinical Trial

187

Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis

188

Oral choristoma in one and a half year-old ouda ewe: a case report

189

Oral chromoblastomycosis: a case report

190

Oral cimetidine (Tagamet) for recalcitrant, diffue conjunctival papillomatoi

191

Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study

192

Oral Ciprofloxacin Compared with Intravenous Ceftazidim on Low Risk Febrile Neutropenia in Acute Lymphocytic Leukemia

193

Oral Ciprofloxacin Prophylaxis in Patients Undergoing High Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation

194

Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment

195

Oral Clefts: A review of the cases and our experience at a single institution

196

Oral Clonidine Premedication Decreases Intraoperative Bleeding in Patients Undergoing Endoscopic Sinus Surgery

197

Oral Clonidine Premedication Reduces Nausea and Vomiting in Children after Appendectomy

198

Oral cobalamin remains medicineʹs best kept secret

199

Oral cobalamin therapy

200

Oral cobalamin therapy for the treatment of patients with food-cobalamin malabsorption

201

Oral colon delivery of insulin with the aid of functional adjuvants

202

Oral colonisation by aerobic and facultatively anaerobic Gram-negative rods and yeast in Tibetans living in Lhasa

203

Oral colonization and cariogenicity of Streptococcus gordonii in specific pathogen-free TAN:SPFOM(OM)BR rats consuming starch or sucrose diets

204

Oral colonization by more than one clonal type of mutans streptococcus in children with nursing-bottle dental caries

205

Oral colonization of Acinetobacter baumannii in intensive care units: Risk factors, incidence, molecular epidemiology, association with the occur of pneumonia and sepsis, and infection control measures

206

Oral Colonization of Staphylococcus Species in a Peritoneal Dialysis Population: A Possible Reservoir for PD-Related Infections?

207

Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkins lymphoma: Evaluation of the role of G-CSF; Quality-of-life analysis and long-term follow-up

208

Oral combination therapy in primary care

209

ORAL COMMUNICATION ABILITY IN ENGLISH: AN ESSENTIAL SKILL FOR ENGINEERING GRADUATES

210

Oral Communication Apprehension (OCA) among Undergraduate Accounting and Journalism Students in Bangladesh

211

Oral Communication Apprehension among English Senior Majors at Al-Quds Open University in Palestine

212

Oral Communication Apprehension and Affective Factors: Self-esteem and Introversion/Extroversion

213

Oral Communication Development in Severe to Profound Hearing Impaired Children After Receiving Aural Habilitation

214

Oral Communication Skills of Engineering Students of Pakistan in Perspective of Industrial Internships

215

Oral communication strategies and multiple intelligences: Exploring the relationship

216

Oral Communication Strategies Used by Iranian EFL Learners and their Relationship with the Learners’ Self-efficacy Beliefs and Anxiety Level

217

Oral Communication Strategies Used by Iranian EFL Learners: Focus on Language Proficiency and Cultural Background

218

Oral Complications of Congestive Heart Failure Drugs in Patients Referred to Heart Clinics in Birjand (Iran) in 2016

219

Oral Conditions Might Cause Severe Outcomes in Patients With Viral Hepatitis Infection

220

Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women

221

Oral Consumption of D-Glucose Increases Blood Glucose Levels but does not Alter the False Memory Effect using the Deese-Roediger-McDermott task in a Non-Diabetic Sample

222

Oral consumption of Hydro-alcoholic extract of Dactylorhiza maculate (Salep) Prevents Appetite and Body Weight in Male Rats

223

Oral contraception and the recognition of endometritis, ,

224

Oral contraception and the risk of hepatocellular carcinoma

225

Oral contraceptive alert in UK sparks off controversy

226

Oral contraceptive and smoking mortality

227

Oral contraceptive and smoking mortality

228

Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons, , ,

229

Oral contraceptive effects on food choice during the follicular and luteal phases of the menstrual cycle. A laboratory based study

230

Oral contraceptive induced thrombi of the right heart of a heterozygous protein C-deficient woman—a case report

231

Oral contraceptive intake in women with focal nodular hyperplasia of the liver

232

Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis

233

Oral contraceptive pill use and changes in obsessive–compulsive symptoms

234

Oral contraceptive pills and inherited thrombophilia in a young woman with deep venous thrombosis

235

ORAL CONTRACEPTIVE PILLS CONSUMPTION an‎d CEREBRAL VENOUS THROMBOSIS

236

Oral Contraceptive Steroids Promote Papillary Thyroid Cancer Metastasis by Targeting Angiogenesis and Epithelial-Mesenchymal Transition

237

Oral Contraceptive Therapy Increases Oxidative Stress in Pre-Menopausal Women

238

Oral contraceptive use and glucose metabolism in a national sample of women in the United States

239

Oral Contraceptive Use and the Occurrence of Gallstone Disease - A Case-Control Study

240

Oral contraceptive use and venous thromboembolism: Translating epidemiologic data late clinical practice

241

Oral contraceptive use in perimenopause

242

Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis

243

Oral contraceptive-related transverse sinus thrombosis as an initial manifestation of antiphospholipid syndrome in the absence of systemic lupus erythematosus

244

Oral contraceptives and bone mineral density: A population-based study,

245

Oral contraceptives and cervical cancer

246

Oral contraceptives and cervical cancer

247

Oral contraceptives and cervical cancer

248

Oral contraceptives and cervical cancer

249

Oral contraceptives and fatal pulmonary embolism Original Research Article

250

Oral contraceptives and mortality from venous thromboembolism

251

Oral contraceptives and mortality from venous thromboembolism

252

Oral contraceptives and mortality from venous thromboembolism

253

Oral contraceptives and mortality from venous thromboembolism

254

Oral contraceptives and mortality from venous thromboembolism

255

Oral contraceptives and myocardial infarction

256

Oral contraceptives and premenstrual symptoms: Comparison of a 21/7 and extended regimen

257

Oral contraceptives and risk of familial breast cancer

258

Oral contraceptives and risk of hip fractures

259

Oral contraceptives and stroke risk: the debate continues

260

Oral contraceptives and the risk of focal nodular hyperplasia of the liver: A case-control study

261

Oral contraceptives and venous thromboembolism

262

Oral contraceptives and venous thromboembolism

263

Oral contraceptives and venous thromboembolism

264

Oral contraceptives and venous thromboembolism

265

Oral contraceptives and venous thromboembolism

266

Oral contraceptives and venous thromboembolism

267

Oral Contraceptives Can Cause Falsely Low Vitamin B12 Levels

268

Oral contraceptives do not raise risk of heart disease

269

Oral contraceptives that contain ethinyl estradiol (0.035 mg) and cyproterone acetate (2 mg) inhibit leukocyte transmigration through endothelial cell monolayers

270

Oral contraceptives, parity, and cervical cancer

271

Oral corrective feedback in the foreign language classroom: how it affects interaction in analytic foreign language teaching

272

Oral Corrective Feedback Preferences in Iranian L2 Learners with Different Proficiency Levels

273

Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis

274

Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial Original Research Article

275

Oral creatine supplementation in humans does not elevate urinary excretion of the carcinogen N-nitrososarcosine

276

Oral cysticercosis

277

Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: randomized, double-blind, placebo-controlled study

278

Oral d,l-sotalol in atrial fibrillation and/or flutter

279

Oral decitabine reactivates fetal hemoglobin in baboons (Papio anubis)

280

Oral delivery of DNA construct using chitosan nanoparticles to protect the shrimp from white spot syndrome virus (WSSV)

281

Oral delivery of G protein-coupled receptor modulators: An explanation for the observed class difference

282

Oral delivery of heparin: SNAC and related formulations

283

Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells

284

Oral Delivery of Insulin from Trimethyl Chitosan/Tragacanth: In Vitro, MTT, and In Vivo Bioactivity Tests

285

Oral delivery of live yeast Debaryomyces hansenii modulates the main innate immune parameters and the expression of immune-relevant genes in the gilthead seabream (Sparus aurata L.)

286

Oral delivery of proteins by biodegradable nanoparticles

287

Oral delivery of salmon calcitonin

288

Oral delivery of salmon calcitonin

289

Oral developmental toxicity study of methylsulfonylmethane in rats

290

Oral dexamethasone for the treatment of pain in children with acute pharyngitis: A randomized, double-blind, placebo-controlled trial

291

Oral Dexmedetomidine Versus Midazolam as Anesthetic Premedication in Children Undergoing Congenital Heart Surgery

292

ORAL DEXMEDETOMIDINE VERSUS ORAL MIDAZOLAM AS PREMEDICATION IN CHILDREN

293

Oral d-fenfluramine test in treatment-refractory depression: Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group

294

Oral Diagnostic Testing for Detecting Human Immunodeficiency Virus-1 Antibodies: A Technology Whose Time Has Come

295

Oral Diagnostics for the Geriatric Populations: Current Status and Future Prospects

296

Oral dietary supplements before and after surgery

297

Oral dietary supplements before and after surgery

298

Oral dietary supplements in pre- and postoperative surgical patients: a prospective and randomized clinical trial

299

Oral Diphenhydramine-Midazolam Versus Oral Diphenhydramine for Pediatric Sedation in the Emergency Department

300

Oral Direct Renin Inhibition: Premise, Promise, and Potential Limitations of a New Antihypertensive Drug

301

Oral Disease Burden in Patients Undergoing Prosthetic Heart Valve Implantation

302

Oral disorders: unapproved treatments or indications

303

Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetuses

304

Oral doxycycline for neuroborreliosis

305

Oral Doxycycline Reduces the Total Number of Intraocular Bevacizumab Injections Needed to Control Neovascular Age-related Macular Degeneration

306

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

307

Oral drug absorption enhancement by chitosan and its derivatives

308

Oral drug delivery systems using chemical conjugates or physical complexes

309

Oral drug delivery utilizing intestinal OATP transporters

310

Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers

311

Oral drug self-administration: an overview of laboratory animal studies

312

Oral ecosystem alterations in celiac children: A follow-up study

313

Oral Embryonal Rhabdomyosarcom in an Adult Addict Man: a case report and review of literature

314

Oral English Communication Difficulties and Coping Strategies of Diploma of Hotel Management Students at UiTM

315

Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: Comparative pharmacokinetics and drug–drug interactions

316

Oral Erosive Lichen Planus Regression After Thymoma Resection

317

Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: A phase II study with a 5-year follow-up

318

Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men Original Research Article

319

Oral etoposide and palliative treatment for small-cell lung cancer

320

Oral exposure of Kunming mice to diisononyl phthalate induces hepatic and renal tissue injury through the accumulation of ROS. Protective effect of melatonin

321

Oral exposure to the organophosphorus insecticide, Monocrotophos induces intestinal dysfunction in rats

322

Oral extended release of dexamethasone: Montmorillonite–PLGA nanocomposites as a delivery vehicle

323

Oral fecal parasites and personal hygiene of food handlers in Abeokuta, Nigeria

324

ORAL FEEDBACK IN CLASSROOM SLA A Meta-Analysis

325

Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4+ CD45RBhigh T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation

326

Oral fennel (Foeniculum vulgare) drop effect on primary dysmenorrhea: Effectiveness of herbal drug

327

Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers

328

Oral Fibrolipoma: A Report of Two Cases

329

Oral Fibrolipoma-A Rare Histological Entity: Report of 3 Cases and Review of Literature

330

Oral fibrosis among teenagers chewing tobacco, areca nut, and Pan masala

331

Oral findings and health status among hospitalized patients with physical disabilities, aged 60 or above

332

Oral Findings and Salivary Parameters in Children with Celiac Disease: A Preliminary Study

333

Oral findings in children with celiac disease

334

Oral Findings in Newborn Children in and around Mangalore, Karnataka State, India

335

Oral Findings, Salivary Bicarbonate, and Phosphate Levels in Patients with Gastroesophageal Reflux Disease

336

Oral flecainide is not sensitive enough to rule out Brugada-Syndrome

337

Oral Fluid Antibody Detection in the Diagnosis of Gastric Helicobacter pylori Infection

338

Oral fluid collection by post—a pilot study of two approaches

339

Oral fluid proteolytic effects on histatin 5 structure and function

340

Oral Fluid Therapy for Treatment of Neonatal Diarrhoea in Calves

341

Oral fluid therapy in paediatric burns (5–10%): an appraisal

342

Oral Focal Mucinosis: A Case Report and Literature Review

343

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli

344

Oral fumarate for relapsing-remitting multiple sclerosis

345

Oral Functional Assessment Training in Speech Therapy Students using Virtual Reality (VR)

346

Oral functional outcome after intraoral reconstruction with nasolabial flaps

347

Oral fungal infections

348

Oral Gabapentin for the Treatment of Potoperative Pain after Photorefractive Keratectomy Original Reearch Article

349

Oral Gabapentin Treatment for ymptomatic Heimann-Bielchowky Phenomenon

350

Oral Gabapentin Versus Rectal Diclofenac for Postoperative Analgesia

351

Oral ganciclovir fails to prevent CMV in HIV trial

352

Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot study

353

Oral glucocorticoids diminish the efficacy of allergen-specific immunotherapy in experimental feline asthma

354

Oral glucosamine increases expression of transforming growth factor β1 (TGFβ1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: Implications for human efficacy and toxicity

355

Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E

356

Oral glucose retention, saliva viscosity and flow rate in 5-year-old children

357

Oral glucose supplementation improved semen quality and constituents of seminal and blood plasma of NZW buck rabbits in the subtropics

358

ORAL GLUCOSE TOLERANCE TEST (OGTT) IN NORMAL CONTROL AND GLUCOSE INDUCED HYPERGLYCEMIC RATS WITH COCCINIA CORDIFOLIA L. AND CATHARANTHUS ROSEUS L.

359

Oral glucose tolerance test and the preparatory diet,

360

Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts

361

Oral glutamine does not prevent bacterial translocation in rats subjected to intestinal obstruction and Escherichia coli challenge but reduces systemic bacteria spread

362

Oral glutamine prevents DMBA-induced mammary carcinogenesis via upregulation of glutathione production

363

Oral glutamine: does it make sense?

364

Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease

365

Oral glycoprotein IIb/IIIa inhibition—great idea, but it didn’t work

366

Oral Graft-Versus-Host Disease

367

Oral Graft-Versus-Host Disease

368

Oral Granular Cell Tumor: A Case Report with Emphasis on Pseudoepitheliomatous Hyperplasia in Oral Lesions

369

Oral Grapeseed Oil and Sesame Oil in Experimental Acetic Acid-Induced Ulcerative Colitis in Rat

370

Oral Hairy Leukoplakia: Clinical Indicator of an Immunosuppressive Condition and Challenges in Patient Management

371

Oral Health among 35- to 44-Year-Old Iranians

372

Oral health and bone mineral density in postmenopausal women

373

Oral Health and Coronary Artery Disease, A Review Article

374

Oral Health and Coronary Artery Disease, A Review Article

375

Oral Health and Dental Care During Pregnancy

376

Oral health and general health at the early stage of ageing: A review of contemporary studies

377

Oral health and linear growth in primary school children: a five-year longitudinal study

378

Oral Health and Oral Health Related Quality of Life among Elderly People in Iran

379

Oral Health and Pediatricians: Results of a National Survey

380

Oral Health and Quality of Life Among Elderly in Thailand

381

Oral health and quality of life in New Zealand: A social perspective

382

Oral Health and Related Quality of Life in Older People: A Sys-tematic Review and Meta-Analysis

383

ORAL HEALTH AND SALIVARY PROFILES OF GERIATRIC OUTPATIENTS IN CIPTO MANGUNKUSUMO GENERAL HOSPITAL

384

Oral health and school performance in elementary students: A cross-sectional study in a group of Iranian students, Tehran, Iran

385

Oral Health and Treatment Needs among 18-Year-Old Iranians

386

Oral Health Awareness and Practices of Special Needs Caregivers in Qatif, Saudi Arabia

387

Oral Health Awareness and Status among Universiti Kebangsaan Malaysia First Year Dental Students

388

Oral Health Behavior and Its Relationship with Quality of Life among 12 Year-old Children of Rafsanjan in 2017-18

389

Oral health behavior differences between dental students in graduate and doctoral programs

390

Oral Health Behaviors in a Sample of Portuguese Adolescents: An Educational Issue

391

Oral health behaviour and self-esteem in Swedish children

392

Oral Health Behaviours and Preventive Dental Care Experiences Among Patients with Special Health Care Needs at Special Care Dentistry Clinic, University of Malaya

393

Oral health behaviours in relation to caries and gingivitis in primary-school children in Tehran, 2008

394

Oral Health Burden in Children with Systemic Diseases

395

Oral Health Care Behavior in a Group of Turkish Children

396

Oral Health Care Education Regarding the Gingival Health, Knowledge, Attitude, and Behavior of the Pregnant Women

397

Oral Health Change in Iran: Part V; It Is the Time to Focus on MIH by an Electronic Approach - Letter to the Editor

398

Oral Health Characteristics and Dental Rehabilitation of Children with Global Developmental Delay

399

Oral Health Determinants among Opium Users in Kerman, Iran

400

Oral Health Disparities in Older Adults: Oral Bacteria, Inflammation, and Aspiration Pneumonia

401

Oral Health Disparities in the United States

402

Oral Health Disparity in Older Adults: Dental Decay and Tooth Loss

403

Oral health during pregnancy: A study from women with pregnancy

404

Oral health education program among pre-school children: an application of health-promoting schools approach

405

Oral Health Impact Profile and Associated Variables in Southern Brazilian Drug Users

406

Oral Health in Children: A Pediatric Health Priority

407

Oral health in long-term care: The implications of organizational culture

408

Oral health in pregnancy (Guidelines to gynaecologists, general physicians oral health care providers)

409

Oral Health In The Population Of Iasos (Byzantine Period)

410

Oral Health Indices in Patients With Type 2 Diabetes Receiving Insulin Treatment Compared With Metformin: A Cross-sectional Study

411

Oral Health Inequalities among and Within Neo‑Marxian Social Classes in South Korea: A Nationwide Cross‑sectional Study

412

Oral Health Information Being Delivered to Yazd Population in 2011

413

Oral Health Is a Challenging Problem for Patients with Schizophrenia: A Narrative Review

414

Oral Health Issues for Adolescent Athletes

415

Oral Health Knowledge and Attitudes of Community Health Workers in East Azerbaijan, Iran

416

Oral health knowledge and sources of information among male secondary school children in Riyadh

417

Oral health knowledge in parents of Saudi cerebral palsy children

418

Oral health Knowledge of Diabetic Patients before and after the Education Package

419

Oral health knowledge of health care workers in special children’s center

420

Oral health knowledge, attitude and behaviour among Saudi school students in Jeddah city

421

Oral health knowledge, attitude and practices among health professionals in King Fahad Medical City, Riyadh

422

Oral Health Knowledge, Attitude, and Practice among Nursing Students in the NorthEastern Part of Rajasthan, India

423

Oral health knowledge, attitude, and status and oral health index among midwifery students of Tehran University of Medical Sciences, Iran

424

Oral Health Knowledge, Attitude, Behavior, and Self-efficacy Among Healthcare Professionals: A Cross-sectional Study

425

Oral health knowledge, attitudes and practices of people with diabetes in South of Tehran, Iran

426

Oral health knowledge, behaviour and practices among school children in Qatar

427

Oral Health Literacy Among Carers of Special Needs Children in Kuala Terengganu, Malaysia

428

Oral Health Literacy and Behaviour of Health Sciences University Students

429

Oral Health Literacy and its Determinants in Young Couples

430

Oral Health Literacy and Oral Health Behavior among Adolescents in Babol 2019

431

Oral Health Literacy and Oral Health Behavior of Senior Medical and Pharmacy Students

432

Oral health literacy and oral health behaviors of disadvantaged women residing in the slum area of Zahedan, Iran: A cross-sectional study

433

Oral Health Literacy in Iran: Insights from a Cross-Sectional Study on the Adult Population

434

Oral health literacy status among adult population of Iran: A systematic review

435

Oral Health Literacy: The New Imperative to Better Oral Health

436

Oral Health of Children with Autism: The Influence of Parental Attitudes and Willingness in Providing Care

437

Oral Health of Down Syndrome Adults in Bosnia and Herzegovina

438

Oral Health of Drug Abusers: A Review of Health Effects and Care

439

Oral health of elderly occupants in residential homes

440

Oral Health of Fasting Muslims

441

Oral health of Iranian children in 2004: a national pathfinder survey of dental caries and treatment needs

442

Oral health of psychiatric patients: A cross-sectional comparision study

443

Oral Health Opinions and Practices of Pediatricians: Updated Results From a National Survey

444

Oral Health Policy Amicable for the South Asian Association for Regional Cooperation Nations

445

Oral Health Policy Development Since the Surgeon Generalʹs Report on Oral Health

446

Oral health problems and mortality

447

Oral Health Professionals Within State-Sponsored Medical Response Teams: The IMERT Perspective

448

Oral Health Profile in Iranian Armed Force: Focusing on Prevention Strategies

449

Oral health related quality of life among adults reffered to dental clinic of Babol faculty of dentistry in 2009-2011

450

Oral health related quality of life and decay-missing-filled teeth in children with attention deficit hyperactivity disorder

451

ORAL HEALTH RELATED QUALITY OF LIFE AND PERIODONTAL STATUS OF A SELECTED MALAYSIAN ADULT POPULATION: A PILOT STUDY

452

Oral Health Related Quality of Life in Diabetic Patients

453

Oral health related quality of life in Indonesian middle-aged and elderly women

454

Oral health related quality of life in patients with diabetes mellitus type 2 in the year 2012

455

Oral health related quality of life in patients with head and neck tumors undergoing chemo and radiotherapy

456

Oral Health Related Quality of Life of Patients Using Conventional Dentures versus Implant-Supported Overdentures

457

Oral Health Status and its Determinants among a Group of Iranian Employees

458

Oral health status and oral health behavior of substance abusers in Kerman city, Iran, in year 2016

459

Oral health status and oral hygiene behaviour of orphan children: A survey in support centers in Kerman City, Iran, in 2019

460

Oral Health Status and Related Factors among Adult Patients Referred to Public Health Centers (Kerman-Iran)

461

oral health status and related factors in children with visual impairment aged 7-11 years: a cross-sectional study

462

Oral Health Status and Salivary Properties Among Children Before and After Tonsillectomy

463

ORAL HEALTH STATUS AND TREATMENT NEEDS OF A SCREENED UNIVERSITY POPULATION IN PORT HARCOURT, RIVERS STATE

464

Oral Health Status and Treatment Needs of Visual Impairment in Phitsanuloke, Thailand

465

Oral health status in patients with epilepsy

466

Oral health status in preschool asthmatic children in Iran.

467

Oral Health Status in the Iranian Elderly: The Role of Nutrition Status and Health Literacy

468

Oral Health Status in the Pars Cohort Study

469

Oral Health Status in Three Long Term Care Units of Schizophrenic Patients in Chaharmahal-Bakhtiari Province, Iran

470

Oral Health Status of 12 and 15YearOld Students in Qatar: Findings From the National Oral Health Survey

471

Oral health status of 12-year-old male schoolchildren in Medina, Saudi Arabia

472

Oral health status of a sample of disabled population in Iran

473

Oral Health Status of Children with Autistic Spectrum Disorder Compared with Non-authentic Peers

474

Oral Health Status of Children with Disability Living in Albania

475

Oral health status of disabled children

476

Oral Health Status of Low Birth Weight and Preterm Children

477

Oral health status of male adolescent smokeless tobacco users in Saudi Arabia

478

Oral Health Status of Patients Visiting Islamic International Dental Hospital

479

Oral health status of school children in Mbarara, Uganda

480

Oral health status of southern Chinese following head and neck irradiation therapy for nasopharyngeal carcinoma

481

Oral Health Status of the Professional Soccer Players in Thailand

482

Oral health status, dental needs, habits and behavioral attitude towards dental treatment of a groupof autistic children in Riyadh, Saudi Arabia

483

Oral health status, knowledge, attitude and practice of patients with heart disease

484

Oral health status, salivary flow rate and salivary quality in children, adolescents and young adults with ADHD

485

Oral health status, salivary pH status, and Streptococcus mutans counts in dental plaques and saliva of children with acute lymphoblastic leukemia

486

Oral health status, self‑perceived dental needs, and barriers to utilization of dental services among people with psychiatric disorders reporting to a tertiary care center in Haryana

487

Oral health, sociodemographic factors, dietary and oral hygiene practices in Jordanian children

488

Oral Health-Related Factors based on Health Belief Model in 10th to 12th-Grade Students in Kashan

489

Oral Health-Related Quality of Life among Parents and Teachers of Disabled Schoolchildren in Kuwait

490

Oral Health-Related Quality of Life Changes Following Third Molar Surgery in a Jordanian Population: Effect of Demographic and Clinical Factors on the Immediate Postoperative Period

491

Oral Health‑related Quality of Life in Older People in Kashan/Iran 2015

492

Oral Health-Related Quality of Life in Temporomandibular Disorder Patients Treated with Stabilization Splint

493

Oral health-related quality of life: a broader perspective

494

Oral Health-Related Quality of Life: A Cross-Sectional Survey among Adult Patients in Mashhad, Iran

495

Oral Hemorrhage in a 3-year-old Boy Caused by Self-Mutilating Behavior

496

Oral herbal supplement containing magnesium sulfate improve metabolic control and insulin resistance in non-diabetic overweight patients: A randomized double blind clinical trial

497

Oral herpetic infections (HSV 1–8)

498

Oral Histoplasmosis: Report of Two Cases

499

Oral Hobnail Hemangioma: A Case Report

500

Oral hygiene assessment by school teachers and peer leaders using simplified method

501

Oral hygiene awareness among female Saudi school children

502

Oral hygiene awareness among female Saudi school children

503

Oral Hygiene Behaviors and Oral Health Literacy Among Informal Thai Workers in Rural Areas

504

Oral Hygiene Behaviour Change in Dentistry Students During Dental Education

505

Oral hygiene evaluation for effective oral care in preventing pneumonia in dentate elderly

506

Oral Hygiene Evaluation Of The Patients Before Orthodontic Treatment

507

ORAL HYGIENE HABITS AND ORAL HEALTH STATUS OF FEMALE ADOLESCENTS UNDER STATE PROTECTION: A PILOT STUDY

508

Oral Hygiene Practices and Bottle Feeding Pattern Among Children with Early Childhood Caries: A Preliminary Study

509

Oral hygiene practices and dietary habits among children with Down’s Syndrome in Riyadh, Saudi Arabia

510

Oral hygiene reduces respiratory infections in elderly bed-bound nursing home patients

511

Oral Hygiene Status in a General Population of Iran, 2011: A Key Lifestyle Marker in Relation to Common Risk Factors of Non-Communicable Diseases

512

Oral hygiene status of Kuwaiti schoolchildren

513

Oral hypoglycemic agents in coronary artery bypass grafting

514

Oral hypoglycemics sold as valium on the streets: A case report

515

Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis

516

Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens

517

Oral Ibuprofen for Closure of Hemodynamically Significant Patent Dultus Arteriosus in Premature Neonates: a Pilot Study

518

Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term

519

Oral imipramine and intravenous xylazine for pharmacologically-induced ex copula ejaculation in stallions

520

Oral immunisation of pigs with fimbrial antigens of enterotoxigenic E. coli: an interesting model to study mucosal immune mechanisms

521

Oral immunisation of pigs with fimbrial antigens of enterotoxigenic E. coli: an interesting model to study mucosal immune mechanisms

522

Oral immunization induces local and distant mucosal immunity in swine

523

Oral immunization induces local and distant mucosal immunity in swine

524

Oral immunization of olive flounder (Paralichthys olivaceus) with recombinant live viral hemorrhagic septicemia virus (VHSV) induces protection against VHSV infection

525

Oral immunization of rainbow trout to infectious pancreatic necrosis virus (Ipnv) induces different immune gene expression profiles in head kidney and pyloric ceca

526

Oral immunization of the African clawed frog (Xenopus laevis) upregulates the mucosal immunoglobulin IgX

527

Oral immunization of the African clawed frog (Xenopus laevis) upregulates the mucosal immunoglobulin IgX

528

Oral Immunization with Enterocoated Microbeads Induces Antigen-Specific Cytolytic T-Cell Responses

529

Oral immunotherapy for food allergy: Clinical and preclinical studies

530

Oral Immunotherapy in Children: Ige-Dependent Food Allergy to Milk or Wheat

531

Oral Immunotherapy to Wheat in Allergic Asthmatic Female: A Case Report

532

Oral Immunotherapy to Wheat in Allergic Asthmatic Female: A Case Report

533

Oral impact on daily performance in Iranian adults

534

Oral Implications of Polypharmacy in the Elderly

535

Oral infection with human papillomavirus 16 common in children

536

Oral Infections and Glycemic Control in Pregnant Type 2 Diabetics

537

Oral infections and systemic diseases

538

Oral infiltrating lipomas

539

Oral ingestion of lidocaine for suicide: A case report

540

Oral inhibitors of platelet membrane receptor glycoprotein IIb/IIIa in clinical cardiology: Issues and opportunities, ,

541

Oral inoculation of Enterococcus faecalis, DNA quantification and histopathological evaluation of gingival, heart and kidney tissue samples in rats

542

Oral inoculation with Gymnorhynchus gigas induces anti-parasite anapyhylactic antibody production in both mice and rats and adverse reactions in challenge mice

543

Oral insulin administration and residual (β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial

544

Oral insulin delivery by self-assembled chitosan nanoparticles: In vitro and in vivo studies in diabetic animal model

545

Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination

546

Oral Intake of Semi-refined Carrageenan by Rats Affects Apoptosis of Lymphocytes

547

Oral intravascular papillary endothelial hyperplasia: a case report

548

Oral involvement in autoimmune blistering diseases

549

Oral iron chelators – development and application

550

Oral Iron Therapy with Polysaccharide-Iron Complex May be Useful in Increasing the Ferritin Level for a Short Time in Patients with Dilated Cardiomyopathy

551

Oral Isobutyramide Therapy in Patients with Thalassemia Intermedia: Results of a Phase II Open Study

552

Oral keratinocytes cultured on dermal matrices form a mucosa-like tissue

553

Oral Ketamine or Nasal Midazolam for Sedation in Pediatric Upper Gastrointestinal Endoscopy

554

Oral ketoprofen is effective in the treatment of non-infectious lameness in sows

555

Oral l -arginine prevents murine coxsackievirus B3 myocarditis

556

Oral laquinimod for treatment of relapsing-remitting multiple sclerosis

557

Oral L-arginine (and other active ingredients) for ischemic heart disease?

558

Oral L-Arginine Administration Improves Anthropometric and Biochemical Indices Associated With Cardiovascular Diseases in Obese Patients: A Randomized, Single Blind Placebo Controlled Clinical Trial

559

Oral l-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men

560

Oral l-arginine supplementation impacts several reproductive parameters during the postpartum period in mares

561

Oral Lesion Description: A Mini Review

562

Oral Lesions among Women Living with or at Risk for HIV Infection

563

Oral Lesions Associated with Human Immunodeficiency Virus Disease

564

Oral Lesions in Kidney Transplant Patients

565

Oral lesions in patients with severe COVID-19 in the National Institute of Respiratory Diseases in Mexico: Case series

566

Oral lesions in Saudi renal transplant patients

567

Oral lesions of 500 habitual psychoactive substance users in Chennai, India

568

Oral leukoplakia: Diagnosis and treatment

569

Oral leukoplakia: Transmission electron microscopic correlation with clinical types and light microscopy

570

Oral Levetiracetam as Add-On Therapy in Refractory Neonatal Seizures

571

Oral Levofloxacin Versus Intravenous Cefotaxime in the Treatment of Patients with Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial

572

Oral levosimendan improves cardiac function and hemodynamics in patients with severe congestive heart failure

573

Oral lichen planus

574

Oral Lichen Planus and Celiac Disease: is there any Relationship?

575

Oral Lichen Planus and Lichenoid Mucositis

576

Oral lichen planus and the burning mouth syndrome. Is there a role for patch testing?

577

Oral lichen planus in a child in association with psychological stress: A case report

578

Oral Lichen Planus in a Pediatric Patient: A Novel Therapeutic Approach

579

Oral Lichen Planus or Oral Lichenoid Reaction? A Literature Review

580

Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study

581

Oral lichen planus: a review

582

Oral Lichen Planus: Clinical Features, Etiology, Treatment and Management; A Review of Literature

583

Oral Lichen Planus: Diagnosis and Management

584

Oral lichen planus: Focus on etiopathogenesis

585

Oral Lichen Planus: Treatment of a Refractory Case (Case Report)

586

Oral Lichenoid Reaction: An Uncommon Side Effect of Rituximab

587

Oral lipid-based formulations

588

Oral Lipoma in Elderly Saudi Patient: A Case Report

589

ORAL LIPOMA: CASE REPORT

590

Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation

591

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study

592

Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC)

593

Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A stress echocardiographic study

594

Oral Lymphoma Prevalence in Iranian Population: A Multicenter Retrospective Study

595

Oral Lymphoma Prevalence in Iranian Population: A Multicenter Retrospective Study

596

Oral Magnesium Supplementation Decreases C-reactive Protein Levels in Subjects with Prediabetes and Hypomagnesemia: A Clinical Randomized Double-blind Placebo-controlled Trial

597

Oral Magnesium Supplementation Improves the Metabolic Profile of Metabolically Obese, Normal-weight Individuals: A Randomized Double-blind Placebo-controlled Trial

598

Oral magnesium supplementation in insulin-requiring patients with type 2 diabetes mellitus

599

Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease

600

Oral Magnesium; Migraine Prophylaxis

601

Oral malignant melanoma: A case report of an unusual clinical and histologic presentation

602

Oral malodor reduction by a palatal mucoadhesive tablet containing herbal formulation

603

Oral Malodor-A Menace To Periodontist

604

Oral malodorous compounds are periodontally pathogenic and carcinogenic

605

Oral management of patients following oncology treatment: literature review

606

Oral manganese intake estimated with dietary records and with direct chemical analysis

607

Oral Manifestation and Caries Experience in Pre-Dialysis Chronic Kidney Disease Patient

608

Oral Manifestation and Dental Management of CATCH 22 Syndrome

609

Oral Manifestation and Presence of Candida albicans in Multiple Sclerosis Disease with Different Treatment Modalities

610

Oral Manifestation Associated with Biochemical and Hematological Changes in Iraqi End-Stage Renal Failure Patients

611

Oral Manifestations and Complications of Diabetes Mellitus

612

Oral Manifestations and Dental Management Considerations of Lipoid Proteinosis: A Case Report and Review of Literature

613

Oral Manifestations and Its Associated Factors in Iranian Systemic Lupus Erythematosus (SLE) Patients

614

ORAL MANIFESTATIONS AND PROSTHETIC REHABILITATION IN HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY (HSAN)TYPE IV: A CASE REPORT

615

Oral manifestations and related factors of HIV positive patients in south-east of Iran

616

Oral manifestations and related factors of HIV positive patients in south-east of Iran

617

Oral manifestations associated with human immunodeficiency virus infection in 200 Indian patients.

618

Oral Manifestations in COVID-19: a Missed Diagnostic Clue or a Mispresented Secondary Complication

619

Oral manifestations in inflammatory bowel disease: A cross‑sectional study in Isfahan

620

Oral manifestations in liver transplant recipients

621

Oral Manifestations in Obesity and Bariatric Surgery: Narrative Review

622

Oral Manifestations in Patients with Psoriasis: A Cross-Sectional Study

623

Oral manifestations in transplant patients

624

Oral manifestations of allograft recipients before and after renal transplantation

625

Oral Manifestations of Aplastic Anemia: A Case Report

626

Oral manifestations of drug therapy

627

Oral Manifestations of Ehlers-Danlos Syndrome and Presentation of a Case

628

Oral manifestations of HIV disease

629

Oral manifestations of HIV infection

630

Oral Manifestations of Human Immunodeficiency Virus-Infected Patients

631

Oral Manifestations of Internal Malignancy and Paraneoplastic Syndromes

632

Oral manifestations of lamellar ichthyosis: A rare case report and review

633

Oral Manifestations of Patients Taking Anti-Hypertensive Medications

634

Oral manifestations of patients with lupus erythematosus

635

Oral manifestations of sexually transmitted diseases

636

Oral manifestations of Systemic Sclerosis and Correlation with anti-Topoisomerase I Antibodies (SCL-70)

637

Oral Manifestations Related To CD4 Lymphocyte Count in HIV-Positive Patients

638

Oral Manifestations With Tissue Alterations of Nas or Pan Consumption: A Case Study in Bandar Abbas (Iran) in 2018

639

Oral mature teratoma containing epididymal tissue in a female neonate

640

Oral melanoma with pulmonary metastasis in a Nigerian local dog

641

ORAL MELANOSIS: A CASE SERIES

642

Oral Melatonin for Colistin-induced Nephrotoxicity Reduction in Intensive Care Unit: A Randomized Placebo Controlled Clinical Trial

643

Oral melatonin in neurologically disabled children

644

Oral melatonin in neurologically disabled children

645

Oral melatonin in neurologically disabled children

646

Oral Melatonin Versus Midazolam as Premedication for Intravenous Sedation in Pediatric Dental Patients

647

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

648

Oral metastases: report of 24 cases

649

Oral Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report

650

Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion,

651

Oral methotrexate for treatment of ectopic pregnancy

652

Oral Methylated N-Aryl Chitosan Derivatives for Inducing Immune Responses to Ovalbumin

653

ORAL MICROBES AND ITS ENVIRONMENT: A REVIEW ARTICLE

654

Oral microbial colonization in children with sickle cell anaemia under long-term prophylaxis with penicillin

655

Oral Microbiome in Head and Neck Cancers: An Insight, Are We Looking at a Step Beyond in Unraveling the Challenge?

656

Oral Microflora in Patients on Hemodialysis and Kidney Transplant Recipients

657

Oral microflora of stray domestic cats (Felis catus) found in the premises of two human hospitals in Sokoto, Nigeria

658

Oral Midazolam and Emergence Delirium

659

Oral Midazolam for Voiding Dysfunction in Children Undergoing Voiding Cystourethrography: A Controlled Randomized Clinical Trial

660

Oral Midazolam Vs Promethazine as Pre Sedation Medication in Pediatric Dentistry

661

Oral Midazolam-Ketamine versus Midazolam alone for Procedural Sedation of Children Undergoing Computed Tomography; a Randomized Clinical Tri-al

662

Oral misoprostol for postpartum haemorrhage

663

Oral misoprostol for premature rupture of membranes at term

664

Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial

665

Oral misoprostol or vaginal dinoprostone for labor induction: A randomized controlled trial

666

Oral misoprostol versus oxytocin in the management of third stage of labour

667

Oral morphine consumption reduces lens development in rat embryos

668

Oral morphology and dietary choices of goats on rangeland

669

Oral motor patterns during feeding in severely physically disabled children

670

Oral mucoceles: A clinical, histopathological and immunohistochemical study

671

Oral mucosa and Streptococcus mutans count in the saliva. Does graphene oxide nanoparticle mouthwash have a good effect?

672

Oral mucosa grafts for urethral reconstruction

673

Oral mucosa lesions and risk habits: a cross-sectional study in North Serbia student population

674

ORAL MUCOSA MYIASIS CAUSED BY OESTRUS OVIS

675

Oral mucosal embryology and histology

676

Oral Mucosal Lesions and Adverse Habits Among Hospitalized Tuberculosis Patients of Udaipur, Rajasthan, India

677

Oral mucosal lesions and developmental anomalies in dental patients of a teaching hospital in Northern Taiwan

678

Oral mucosal lesions and risk factors in elderly dental patients

679

Oral mucosal lesions in complete denture wearers

680

Oral mucosal lesions: a retrospective review of one institution’s 13-year experience

681

Oral mucosal manifestations in primary and secondary Sjögren syndrome and dry mouth syndrome

682

Oral mucosal pigmentation secondary to treatment with mepacrine, with sparing of the denture bearing area

683

Oral mucosal wetness in hypo- and normosalivators

684

685

Oral mucositis in patients with leukaemia following high-dose chemotherapy and autologous haematopoietic stem cells transplantation

686

Oral Mucositis Prevention and Management by Therapeutic Laser in Head and Neck Cancers

687

Oral Mucous Membrane Pemphigoid With Positive Nikolsky’s Sign: A Case Report

688

Oral multiple sclerosis treatment gains support

689

Oral Myiasis Affecting Gingiva in a Child Patient: An Uncommon Case Report

690

Oral myiasis by screwworm Cochliomyia hominivorax

691

Oral Myiasis: A Rare Case Report and Literature Review

692

Oral Narratives by Hearing-Impaired Students in Ordinary Schools- A SFG Study

693

Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor

694

Oral Nitrate Reductase Activity Is Not Associated with Development of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Pilot Study

695

Oral nodular fasciitis: case report

696

Oral Oncoprevention by Phytochemicals - A Systematic Review Disclosing the Therapeutic Dilemma

697

Oral Opportunistic Bacteria in Multiple Sclerosis with Different Treatment Modalities

698

Oral or intravenous methylprednisolone for acute relapses of MS?

699

Oral or Intravenous N-Acetylcysteine for Acetaminophen Poisoning?

700

Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia

701

Oral or parenteral therapy for B12 deficiency

702

Oral or parenteral therapy for vitamin B12 deficiency

703

Oral or parenteral therapy for vitamin B12 deficiency

704

Oral or parenteral therapy for vitamin B12 deficiency

705

Oral or rectal diclofenac for laparoscopic sterilization

706

Oral or topical administration of L-arginine changes the expression of TGF and iNOS and results in early wounds healing

707

Oral ornithine a-ketoglutarate accelerates healing of thesmall intestine and reduces bacterial translocation after abdominal radiation

708

Oral Oxycodone Compared With Intravenous Morphine Sulfate for Pain Management of Isolated Limb Trauma; a Randomized Clinical Trial

709

Oral Papillomatosis in a Dog: Surgical Management and Histopathological Findings

710

Oral Paraneoplastic Pemphigus and Pharyngeal Squamous Cell Carcinoma: A Rare Case Report and Review of Literature

711

Oral pathology – Pertinent papers published in 2002–2003: A personal view

712

Oral pathology – Pertinent papers published in 2004: A personal view

713

Oral pemphigoid autoantibodies preferentially target BP180 ectodomain

714

Oral peptide drug delivery: polymer–inhibitor conjugates protecting insulin from enzymatic degradation in vitro

715

ORAL PERFORMANCE AS SIREN The Example of Ozoemena Nwa Nsugbe

716

Oral pH and drinking habit during ingestion of a carbonated drink in a group of adolescents with dental erosion

717

Oral phenylalanine loading test for the diagnosis of dominant guanosine triphosphate cyclohydrolase 1 deficiency

718

Oral physostigmine in alzheimerʹs disease: Effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma

719

Oral pigmented lesions

720

Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial

721

Oral pleasure and expatriate satisfaction: an empirical approach

722

Oral poliomyelitis vaccines

723

Oral Potentially Malignant Disorders: An Overview of More than 20 Entities

724

Oral prednisolone for viral wheeze in young children

725

Oral prednisolone for viral wheeze in young children

726

Oral prednisolone in the treatment of cervical radiculopathy: A randomized placebo controlled trial

727

Oral premalignancies and squamous cell carcinoma

728

Oral Premedication for Pediatric Cardiac Surgery: A Comparison of Midazolam, Ketamine and Midazolam plus Ketamine

729

Oral premedication in patients with a history suggesting hypersensitivity to iodinated contrast media

730

Oral Presentation Versus Role Playing in Medical Education: A Quasi-Experimental Study

731

Oral Presentation vs. Free Discussion: Iranian Intermediate EFL Learners’ Speaking Proficiency and Perception

732

Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD− S. Typhi-specific IgA and IgG B memory cells in humans

733

ORAL PROBIOTIK: PENDEKATAN BARU TERAPI HALITOSIS (Tinjauan Pustaka)

734

Oral Problems and Psychological Status of Older Adults Referred to Hospital and Its Relationship With Cognition Status, Stress, Anxiety, and Depression

735

Oral processing characteristics of solid meal components, and relations with food composition, sensory attributes & expected-satiation

736

Oral processing characteristics of solid savoury meal components, and relationship with food composition, sensory attributes and expected satiation

737

Oral processing, texture and mouthfeel: From rheology to tribology and beyond

738

Oral Propranolol for Treatment of Pediatric Capillary Hemangiomas

739

Oral propranolol premedication and hypotensive anesthesia in shoulder arthroscopic surgery: a randomized controlled double-blind study

740

Oral propranolol versus cryotherapy in the management of cutaneous hemangioma in infants and children

741

Oral Psyllium Herbal Laxative , Clinical Trial in a Difficult Group

742

Oral Pulse Granuloma- A Rare Entity

743

Oral Pushed Output: the Route to Longterm Grammatical Accuracy

744

Oral pyogenic granuloma: a review of 38 cases from Ibadan, Nigeria

745

Oral Quercetin Supplementation Enhances Adiponectin Receptor Transcript Expression in Polycystic Ovary Syndrome Patients: A Randomized Placebo-Controlled Double-Blind Clinical Trial

746

Oral Question Approach In Teaching By Malay Language Teachers: Observation Methode

747

Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis: The Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study Original Research Article

748

Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: The Oral Rapamune to Inhibit Restenosis (ORBIT) study Original Research Article

749

Oral rapamycin to prevent human coronary stent restenosis: A pilot study

750

Oral recombinant bovine somatotropin improves growth performance in rainbow trout (Oncorhynchus mykiss)

751

Oral Recombinant Mycobacterium bovis Bacillus Calmette–Guérin Expressing HIV-1 Antigens as a Freeze-Dried Vaccine Induces Long-Term, HIV-Specific Mucosal and Systemic Immunity

752

Oral Reconstruction of Hemi-Mandibulectomy Patients by Implant Overdenture: Report of Two Cases

753

Oral reconstruction using the peroneal flap

754

Oral Reference Dose for ethylene glycol based on oxalate crystal-induced renal tubule degeneration as the critical effect

755

Oral rehabilitation after radiotherapy; a review on prosthetic treatment options

756

Oral Rehabilitation and Management for Secondary Sjögren’s Syndrome in a Child

757

Oral rehabilitation by semi‑adjustable articulator

758

Oral Rehabilitation in Irradiated Patients: Implant- or Tooth-Supported Fixed Prosthesis? A Clinical Report

759

Oral Rehabilitation of a Patient with Papillon Lefèvre Syndrome Using Fixed Full-Arch Hybrid Prostheses Supported by Four Axially Loaded Implants: A Case Report with Four-Year Follow-up

760

Oral rehabilitation of amelogenesis imperfecta by complete overdentures: Case Report

761

Oral Rehabilitation of an Osteopetrosis Patient with Osteomyelitis

762

Oral Rehabilitation Using the Lip Muscle Trainer: A Narrative Review

763

Oral rehydration and hyponatraemia

764

Oral rehydration solution as adjuvant for oral vaccination

765

Oral rehydration solutions

766

Oral rehydration solutions for diabetics with acute diarrhoea

767

Oral rehydration therapy

768

Oral rehydration therapy improved for cholera

769

Oral renin inhibitors

770

Oral Requests in Advanced Level English Coursebooks and English Movies: An Evaluative Study

771

Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies

772

Oral retinoids pose no threat to back bones

773

Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: A systematic review of the evidence from comparative trials Review Article

774

Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: A new potential treatment of osteoarthritis

775

Oral Schwannoma: A Systematic Review of the Case Reports

776

Oral Schwannoma: A Systematic Review of the Case Reports

777

Oral sealing using glue: a new method to distinguish between intestinal and dermal uptake of metals in earthworms

778

Oral sealing using glue: a new method to distinguish between intestinal and dermal uptake of metals in earthworms

779

Oral Selenium: Can It Prevent Contrast-Induced Nephropathy Following Coronary Angiography and Angioplasty

780

Oral self emulsifying powder of lercanidipine hydrochloride: Formulation and evaluation

781

Oral Self-Injurious Behaviors in Patients with Developmental Disabilities

782

Oral sensation of ethanol in a primate model III: responses in the lingual branch of the trigeminal nerve of Macaca mulatta

783

Oral sensations associated with the flavan-3-ols (+)catechin and (-)-epicatechin

784

Oral sensorimotor function for feeding in patients with tetanus

785

Oral sensory and cephalic hormonal responses to fat and non-fat liquids in bulimia nervosa

786

Oral Sildenafil After Bidirectional Cavopulmonary Shunt

787

Oral Sildenafil Ameliorates Impaired Pulmonary Circulation Early After Bidirectional Cavopulmonary Shunt

788

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

789

Oral sildenafil in erectile dysfunction

790

Oral sildenafil may reverse secondary ejaculatory dysfunction during infertility treatment

791

Oral Sildenafil Reduces Pulmonary Hypertension After Cardiac Surgery

792

Oral sildenafil therapy improves health-related quality of life and functional status in pulmonary arterial hypertension

793

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

794

Oral single pulse exposure of flounder Platichthys flesus to 4-tert-octylphenol: Relations between tissue levels and estrogenic effects

795

Oral single-dose pharmacokinetics of thiamphenicol in the sea-bass (Dicentrarchus labrax)

796

Oral single-dose pharmacokinetics of thiamphenicol in the sea-bass (Dicentrarchus labrax)

797

Oral Smokeless Tobacco Use with Special Reference to India

798

ORAL SNUFF AND CARCINOMA OESOPHAGUS

799

Oral Sodium Thiosulfate Solution as a Secondary Preventive Treatment for Calciphylaxis in Dialysis Patients

800

Oral solitary fibrous tumor: a cytogenetic analysis of tumor cells in culture with literature review

801

Oral species of Fusobacterium from human and environmental samples

802

Oral splint for temporomandibular joint disorders with revolutionary fluid system

803

Oral squamous cell cancer protein-protein interaction network interpretation in comparison to esophageal adenocarcinoma

804

Oral Squamous Cell Carcinoma and the Cutting Edge of Nanotechnology

805

Oral squamous cell carcinoma cells modulate osteoclast function by RANKL-dependent and -independent mechanisms

806

Oral Squamous Cell Carcinoma with an Unusual Clinical Manifestation: A Case Report

807

ORAL SQUAMOUS CELL CARCINOMA WITH PSEUDO-GLANDULAR DIFFERENTIATION

808

Oral Squamous Cell Carcinoma: Focus on Biomarkers for Screening

809

Oral squamous cell carcinoma: Like owner, like cat

810

Oral statins and increased bone-mineral density in postmenopausal women Original Research Article

811

Oral status and nutrition in the institutionalized elderly

812

Oral Stereognosis in Children With Cleft Palate and Normal Children

813

Oral steroids as a cause of diverticulum perforation

814

Oral sterol intake in The Netherlands: evaluation of the results obtained by GC analysis of duplicate 24-h diet samples collected in 1994

815

Oral Story as Source for Tourism: A Comparative between Malaysia and Singapore

816

Oral Storytelling as an Act of Resistance in Morrison’s Tar Baby

817

Oral Sub Mucous Fibrosis: Exploring Therapeutic Strategies Using -anti TGF β Drugs

818

Oral subchronic and genotoxicity studies conducted with the amino acid, l-glutamine

819

Oral submucous fibrosis and copper

820

Oral Submucous Fibrosis in a 15-year-old Boy: The First Case Report in Iran

821

Oral Submucous Fibrosis: a case report

822

Oral Submucous Fibrosis: A Chronic Deliberating Disease of Oral Cavity

823

Oral Substitution of Melatonin in Critical Care: A Pharmacokinetic Study in Patients with Intracranial Hemorrhage

824

Oral substitution treatments for opioid dependence

825

Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway

826

Oral Supplementation of B-Carotene Significantly Ameliorates Testicular Oxidative Stress in the Streptozotocin-Diabetic Rat

827

Oral Supplementation of β-Carotene Significantly Ameliorates Testicular Oxidative Stress in the Streptozotocin-Diabetic Rat

828

Oral supplements as adjunctive treatment to nutritionalcounseling in malnourished HIV infected patients: randomized controlled trial

829

Oral supplements differing in fat and carbohydrate content: effect on the appetite and food intake of undernourished elderly patients

830

Oral Surgery for Patients on Anticoagulant Therapy: Current Thoughts on Patient Management

831

ORAL SUSTAINED RELEASE PELLETS OF DILTIAZEM HCL WITH KOLLICOAT SR30

832

Oral Syphilis: A Reemerging Infection Prompting Clinicians’ Alertness

833

Oral Taurine Supplementation Modulates Ethanol-Conditioned Stimulus Preference

834

Oral Teratogenicity Studies of Methyl Bromide in Rats and Rabbits

835

Oral terbutaline after parenteral tocolysis: A randomized, double-blind, placebo-controlled trial

836

Oral terbutaline in the outpatient management of preterm labor

837

Oral testosterone supplementation and chronic low-grade inflammation in elderly men: A 26-week randomized, placebo-controlled trial

838

Oral Theophylline Changes Renal Carnitine Palmitoyltransferase Activity in Rats

839

Oral therapeutics and oral cosmetics

840

Oral Therapy in a Diabetic Patient With History of Infantile Hyperinsulinism

841

Oral Thioctic Acid (a-Lipoic Acid) and Gabapentin as Co-adjuvants in Paraneoplastic Neuropathic Pain

842

Oral tolerance and autoimmune diabetes—will hope triumph over experience?

843

Oral tolerance and OVA-induced tolerogenic dendritic cells reduce the severity of collagen/ovalbumin-induced arthritis in mice

844

Oral tolerance correlates with high levels of lymphocyte activity

845

Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis-inducedand high-fat-diet-driven atherosclerotic lesions

846

Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells

847

Oral tolerance: Mechanisms and possible role in inflammatory joint diseases

848

Oral Tolerance: New Approaches, New Problems

849

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

850

Oral toxic exposure of titanium dioxide nanoparticles on serum biochemical changes in adult male Wistar rats

851

Oral toxic exposure of titanium dioxide nanoparticles on serum biochemical changes in adult male Wistar rats

852

Oral Toxicity and Carcinogenicity Studies of Sucrose Acetate Isobutyrate (SAIB) in the Fischer 344 Rat and B6C3F1 Mouse

853

ORAL TOXICITY AND REPELLENT EFFECT OF SOME INSECTICIDES AGAINST HONEYBEE WORKERS

854

Oral toxicity evaluation of kefir-isolated Lactobacillus kefiranofaciens M1 in Sprague–Dawley rats

855

Oral toxicity of a tocotrienol preparation in rats

856

Oral Toxicity of Bis(2-Ethylhexyl) Phthalate During Pregnancy and Suckling in the Long–Evans Rat

857

Oral Toxicity of Thymol, α-Pinene, Diallyl Disulfide and Trans-Anethole, and Their Binary Mixtures against Tribolium castaneum Herbst Larvae (Coleoptera: Tenebrionidae)

858

Oral toxicological studies of black soybean (Glycine max) hull extract: Acute studies in rats and mice, and chronic studies in mice

859

Oral Tradition and Identity of West Kalimantan Society

860

Oral tranexamic acid in treatment of melasma in Pakistani population: a pilot study

861

Oral transmission of BSE to primates

862

Oral transmucosal drug delivery for pediatric use

863

Oral treatment of transmissible gastroenteritis with natural human interferon alpha: A field study

864

Oral treatment of transmissible gastroenteritis with natural human interferon alpha: A field study

865

Oral treatment options for degenerative joint disease—presence and future

866

Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials

867

Oral trovafloxacin compared with intravenous cefoxitin in the prevention of bacterial infection after elective vaginal or abdominal hysterectomy for nonmalignant disease

868

Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity

869

Oral ulcerations due to drug medications

870

Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study

871

Oral vaccination of African catfish with Vibrio anguillarum O2: effect on antigen uptake and immune response by absorption enhancers in lag time coated pellets

872

Oral vaccination of BacFish-vp6 against grass carp reovirus evoking antibody response in grass carp

873

Oral vaccination of dogs with recombinant rabies virus vaccines

874

Oral vaccination of fish againstVibrio anguillarumusing alginate microparticles

875

Oral vaccination of juvenile carp (Cyprinus carpio) and gilthead seabream (Sparus aurata) with bioencapsulatedVibrio anguillarumbacterin

876

Oral vaccines against cholera: lessons from Vietnam and elsewhere

877

Oral Verruciform Xanthoma within Lichen Planus: A Case Report and Literature Review

878

Oral Verrucous Carcinoma and Ameloblastoma: A Rare Coincidence

879

Oral Versus Intramuscular Ondansetron for Reducing Vomiting in Children with Acute Gastroenteritis: A Single-Blind Randomized Clinical Trial

880

Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study

881

Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice

882

Oral versus intravenous acetaminophen as a constituent of multimodal analgesia after coronary artery bypass graft surgery: A randomized, blinded trial

883

Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis

884

Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis

885

Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis

886

Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis

887

Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis

888

Oral Versus Intravenous Rehydration of Moderately Dehydrated Children: A Randomized, Controlled Trial

889

ORAL VERSUS NASAL VASOPRESSIN IN THE TREATMENT OF NOCTURNAL ENURESIS IN 5- TO 12-YEAR-OLD CHILDREN

890

Oral versus Parenteral Iron Therapy for correction of Iron Deficiency Anaemia in Pregnancy

891

Oral versus rectal route of misoprostol administration: a randomized controlled trial

892

Oral versus vaginal misoprostol for induction of labor: A double-blind randomized controlled trial

893

Oral Versus Vaginal Misoprostol for Induction of Labour

894

Oral vinorelbine in metastatic breast cancer: A review of current clinical trial results

895

Oral viral infections

896

Oral vitamin b12 therapy in vitamin b12 deficiency

897

Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation

898

Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect

899

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

900

Oral vitamin K prophylaxis for newborn infants: safe enough?

901

Oral Vocabulary as a Predictor of English Language Proficiency among Malaysian Chinese Preschool Children

902

Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: A prospective randomized clinical trial: Mombelli G, Pezzoli R, Pinoja-Lutz G, et al Arch Intern Med 159:53–58 January

903

Oral Wheat Immunotherapy in a Patient with Anaphylaxis Despite Negative Sensitization Tests

904

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

905

Oral Yeast Colonization and Fungal Infections in Peritoneal Dialysis Patients: A Pilot Study

906

Oral Zinc Sulfate as Adjuvant Treatment in Children With Nephrolithiasis: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

907

Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: A double blind, randomized controlled clinical trial

908

ORAL ZINC SULPHATE VS. TOPICAL APPLICATION OF SALICYLIC (16.7%) LACTIC ACID (16.7%) COMBINATION IN THE TREATMENT OF PLANTAR WARTS

909

Oral Zinc Supplementation in Chronically HEV-Infected Patients Not Responding to Ribavirin Monotherapy

910

Oral Zinc Supplementation Positively Affects Linear Growth, But not Weight, in Children 6‑24 Months of Age

911

Oral, gastric and intestinal influences on the control of appetite and feeding in humans

912

Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer – Review of the literature

913

OralCard: A bioinformatic tool for the study of oral proteome

914

Oral-contraceptive use and risk of hip fracture: a case-control study

915

ORAL-DENTAL HEALTH PROTOCOLS IN PEDIATRIC INTENSIVE CARE UNITS

916

Oral-facial-digital syndrome type II: Transitional type between Mohr and Varadi

917

Oral-facial-digital syndrome type VI with self mutilations

918

Oral-facial-digital syndrome with mesoaxial polysyndactyly,common AV canal,hirschsprung disease and sacral dysgenesis: Probably a transitional type between II,VI,variant of type VI or a new type

919

Oral-health status of inpatients with schizophrenia in Taiwan

920

Orality and literacy in public discourse: An interview of Hannah Arendt

921

Orality and the Sermonic Tradition in J. California Cooperʹʹs Some People, Some Other Place- A Study of the Narrative Voice

922

Orality in the library: How mobile phones challenge our understandings of collaboration in hybridized information centers Original Research Article

923

Orality to literacy: effects on nursing knowledge

924

Orality, Storytelling the Metafictional Space of Narration in Stephen Crane’s The Red Badge of Courage

925

Orall -arginine improves endothelial dysfunction in patients with essential hypertension

926

Oral-Language Skills of the Iranian Pupils With Hearing-Impairment

927

Orally active 1,2,4-trioxepanes: Synthesis and antimalarial activity of a series of 7-arylvinyl-1,2,4-trioxepanes against multidrug-resistant Plasmodium yoelii in Swiss mice Original Research Article

928

Orally active 4-amino-5-diarylurea-furo[2,3-d]pyrimidine derivatives as anti-angiogenic agent inhibiting VEGFR2 and Tie-2

929

Orally active amino functionalized antimalarial 1,2,4-trioxanes

930

Orally active antimalarials: Synthesis and bioevaluation of a new series of steroid-based 1,2,4-trioxanes against multi-drug resistant malaria in mice

931

Orally active anti-proliferation agents: novel diphenylamine derivatives as FGF-R2 autophosphorylation inhibitors

932

Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety Original Research Article

933

Orally active cephalosporins. Part 2: Synthesis, structure–activity relationships and oral absorption of cephalosporins having a C-3 pyridyl side chain Original Research Article

934

Orally active cephalosporins. Part 3: synthesis, structure–activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporins Original Research Article

935

Orally Active Cephalosporins. Part 4: Synthesis, Structure–Activity Relationships and Oral Absorption of Novel 3-(4-Pyrazolylmethylthio)cephalosporins with Various C-7 Side Chains Original Research Article

936

Orally active cephalosporins: synthesis, structure–activity relationships and oral absorption of 3-[(E) and (Z)-2-Substituted vinyl]-cephalosporins Original Research Article

937

Orally active docetaxel analogue: synthesis of 10-deoxy-10-C-morpholinoethyl docetaxel analogues

938

Orally active esters of dihydroartemisinin: Synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice

939

Orally active factor Xa inhibitor: synthesis and biological activity of masked amidines as prodrugs of novel 1,4-diazepane derivatives Original Research Article

940

Orally active factor Xa inhibitors: 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine derivatives

941

Orally active factor Xa inhibitors: Investigation of a novel series of 3-amidinophenylsulfonamide derivatives using an amidoxime prodrug strategy

942

Orally active indole N-oxide PDE4 inhibitors

943

Orally active inhibitors of stromelysin-1 (MMP-3)

944

Orally active insulin mimics: where do we stand now?

945

Orally active iron chelators

946

Orally active PDE4 inhibitors with therapeutic potential

947

Orally active prostacyclin analogue in primary pulmonary hypertension

948

Orally active thrombin inhibitors. Part 1: Optimization of the P1-moiety

949

Orally active thrombin inhibitors. Part 2: Optimization of the P2-moiety

950

Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice

951

Orally administered heparin for preventing deep venous thrombosis

952

Orally administered LPS enhances head kidney macrophage activation with down-regulation of IL-6 in common carp (Cyprinus carpio)

953

Orally Administration of Propranolol, Lorazepam, and Combination of Propranolol/Lorazepam, and Reducing Anxiety Before Surgery

954

Orally Administration of Propranolol, Lorazepam, and Combination of Propranolol/Lorazepam, and Reducing Anxiety Before Surgery

955

Orally and transdermally replaced estradiol improves endothelial function equally in middle-aged women after surgical menopause

956

Orally available cidofovir derivative active against smallpox

957

Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus

958

Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics

959

Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model

960

Orally bioavailable prodrugs of a BCS class 2 molecule, an inhibitor of HIV-1 reverse transcriptase

961

Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K

962

Orally bioavailable, indole-based nonpeptide GnRH receptor antagonists with high potency and functional activity

963

Orally disintegrating tablets prepared by a co-processed mixture of micronized crospovidone and mannitol using a ball mill to improve compactibility and tablet stability

964

Orally Disintegrating Tablets: A Review

965

Orally Efficacious NR2B-Selective NMDA Receptor Antagonists

966

Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif

967

Orally provoked urinary nickel excretion during disulfiram treatment

968

Oralmucoadhesive paste of Triamcinolone Acetonide and Zinc Sulfate: Preparation and in vitro physicochemical characterization

969

Oral-Periodontal Health and Cytokine Storm: Correlation and Preventive Measures

970

Oral-to-inhalation route extrapolation in occupational health risk assessment: a critical assessment

971

Orang Asli (aboriginal) community participation in the tourism industry - A preliminary survey of Belum-Temenggor

972

Orang Asli Talks in Akiya’s Tuntut

973

Orang Kulisusu. Identitas dan Kekuasaan Reproduksi Identitas Kultural dalam Proses Pemekaran Kabupaten Buton Utara

974

Orang Pekak Sebagai Cacat Atau Pengguna Minoriti Bahasa: Perspektif Perubatan Dan Linguistik

975

Orang Suku Laut dan Orang Melayu di Kepulauan Riau: Sebuah Tafsir Deskriptif-Etnografis

976

Orange (Citrus sinensis) juice concentration by reverse osmosis Original Research Article

977

Orange and green monkeys jumping around the room

978

Orange and red organic light-emitting devices using aluminum tris(5-hydroxyquinoxaline)

979

Orange and Sunlight: A Recipe for Blisters

980

Orange emission enhancement by energy transfer in Sr3Al2O5Cl2:Ce3+, Eu2+ phosphor for solid-state lighting

981

Orange emissive phosphor for warm-white light-emitting diodes

982

Orange G and Remazol Brilliant Blue R decolorization by white rot fungi Dichomitus squalens, Ischnoderma resinosum and Pleurotus calyptratus

983

Orange Harvesting Systems Review Review Article

984

Orange Hot’ Anthurium

985

Orange II adsorption on palygorskites modified with alkyl trimethylammonium and dialkyl dimethylammonium bromide — An isothermal and kinetic study

986

Orange II photocatalysis on immobilised TiO2: Effect of the pH and H2O2

987

Orange is good for health of hunters

988

Orange juice concentration by osmotic evaporation and membrane distillation: A comparative study Original Research Article

989

Orange juice—anticancer activity

990

Orange juice—anticancer activity

991

Orange Luminescence and Structural Properties of Three Isostructural Halocyclohexylisonitrilegold(I) Complexes

992

Orange oil stability in spray dry delivery systems

993

Orange peel as an adsorbent in the removal of Acid violet 17 (acid dye) from aqueous solutions

994

Orange Peel Essential Oil as Component of a Metal Sensor for Lead (II) Ion Determination in Aqueous Solutions

995

Orange peel pretreatment in a novel lab-scale direct steam-injection apparatus for ethanol production

996

Orange pulp improves antioxidant status and suppresses lipid peroxidation in orchidectomized male rats

997

Orange tree simulation under heterogeneous environment using agent-based model ORASIM

998

Orange-spotted grouper (Epinephelus coioides) TLR2, MyD88 and IL-1β involved in anti-Cryptocaryon irritans response

999

Orange-spotted grouper (Epinephelus coioides) toll-like receptor 22: Molecular characterization, expression pattern and pertinent signaling pathways

1000

Orangutan population density, forest structure and fruit availability in hand-logged and unlogged peat swamp forests in West Kalimantan, Indonesia Original Research Article

بازگشت